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This work was carried out in a Uruguayan (South American) population to characterize aging-associated physiological arterial
changes. Parameters markers of subclinical atherosclerosis and that associate age-related changes were evaluated in healthy people.
Aconservativeapproachwasusedandpeoplewithnonphysiologicalandpathologicalconditionswereexcluded.Then,weexcluded
subjects with (a) cardiovascular (CV) symptoms, (b) CV disease, (c) diabetes mellitus or renal failure, and (d) traditional CV
risk factors (other than age and gender). Subjects (n = 388) were submitted to non-invasive vascular studies (gold-standard
techniques), to evaluate (1) common (CCA), internal, and external carotid plaque prevalence, (2) CCA intima-media thickness
and diameter, (3) CCA stiﬀness (percentual pulsatility, compliance, distensibility, and stiﬀness index), (4) aortic stiﬀness (carotid-
femoral pulse wave velocity), and (5) peripheral and central pressure wave-derived parameters. Age groups: ≤20, 21–30, 31–40,
41–50, 51–60, 61–70, and 71–80 years old. Age-related structural and functional vascular parameters proﬁles were obtained and
analyzed considering data from other populations. The work has the strength of being the ﬁrst, in Latin America, that uses an
integrative approach to characterize vascular aging-related changes. Data could be used to deﬁne vascular aging and abnormal or
disease-related changes.
1.Introduction
Atherosclerotic cardiovascular disease is a leading cause
of morbidity and mortality allover the world. In general
terms, atherosclerosis has a long asymptomatic latent period,
which would provide an opportunity for the development
of eﬀective strategies of treatment and/or prevention. Even
more, an early identiﬁcation of subjects at increased risk
of developing atherosclerosis would be important since
prevention strategies that could have the highest impact in
cardiovascular outcomes at the population level would be
those instituted early. Furthermore, prevention would be
more eﬀective if tailored to individual risk.
Several methods have been proposed to stratify the
cardiovascular risk, taking into account data mainly derived
from European and/or North American populations. Those
methods are mostly based on the identiﬁcation of factors
associated with the etiology and development of atheroscle-
rosis (traditional cardiovascular risk factors). However,
it is noteworthy that given the ethnic diversity in the2 International Journal of Hypertension
atherosclerosis proﬁle, the dissimilar risk associations and
the diﬀerent levels of genetic-environmental interactions in
diﬀerent populations, studies performed in a given popula-
tion could not be directly applied to another (i.e., data from
European people could not be extrapolated to Latin or South
American). Additionally, it is noteworthy that cardiovascular
risk approaches based on the assessment of conventional risk
factors could not be enough to determine the cardiovascular
risk of an individual [1, 2]. In this context, it has been stated
that the early detection of atherosclerosis and the individual
risk stratiﬁcation by means of the evaluation of vascular
parameters could provide a major opportunity to prevent
cardiovascular events [1, 2].
Among others, central aortic pressure, pulse wave
velocity, and the carotid artery arterial wall thickness and
stiﬀness have been proposed as valuable parameters for
the assessment of the individual cardiovascular risk and
for the early detection of vascular damage related with the
atherosclerotic disease [1–3]. Related with this, with rising
frequency, the evaluation of arterial parameters (i.e., stiﬀ-
ness) is considered in clinical practice and in clinical studies.
Thisisexempliﬁedbytheinclusionofthevascularevaluation
in recent guidelines related with hypertension management
and with cardiovascular risk assessment in asymptomatic
adults [1, 2]. However, in spite of its emergence as a useful
tool for risk stratiﬁcation and atherosclerosis assessment,
a widespread implementation of vascular evaluation has
been hampered, among other factors, due to the absence
of a standardized methodology of study, and due to the
lack of established normal and reference values for diﬀerent
populations. Related with this, taking into account the
complexity of age-vascular disease interaction, an important
issue would be the characterization of the structural and
functional vascular changes associated with aging. Such
information would contribute to diﬀerentiate abnormal or
disease-related vascular changes and those expected due to
aging.
Latin America encompasses a wide variety of geographic,
ethnic, and socioeconomic diﬀerences. Such diversity could
be reﬂected in the prevalence/proﬁle of the cardiovascu-
lar risk factors, atherosclerotic vascular changes and/or
in normal/reference values of vascular parameters [4–7].
Considering the described value of evaluating the arterial
function and structure for cardiovascular risk stratiﬁcation
and diagnosis, and the lack of normal and reference levels
of vascular parameters deﬁned taking into account the
diﬀerences among populations, their determination is an
urgent necessity, even more when heterogeneous Latin-
American populations are considered.
The present study was carried out in a Uruguayan
asymptomatic and healthy population to quantify several
complementary vascular parameters considered markers of
arterial aging and subclinical atherosclerosis and to analyze
the age-associated changes in those markers, comparing the
obtained data with those from other populations. To fulﬁll
the described aims, we applied an integrative approach and
we measured several complementary structural and func-
tional vascular parameters, using noninvasive gold standard
methods.
2.MaterialsandMethods
2.1. Study Population and Subjects Groups. CUiiDARTE
Project is a population-based national study developed in
Uruguay. Uruguay, with an area of approximately 176,000
square kilometers (the second-smallest nation of South
America), has a population of approximately 3.5 million,
of which 1.8 million live in Montevideo (Capital) and its
metropolitan area. Most Uruguayans (88%) are Caucasian of
European origin (mainly Spanish).
2.1.1. Subject’s Selection and Groups. Our study was designed
to characterize, in healthy people from Uruguay, the physio-
logical age-associated changes in arterial parameters, mark-
ers of disease. Only by knowing the physiological changes
associatedwithageitispossibletoknowwhetheraparticular
value of a parameter considered marker of vascular disease
is the result of normal aging or reﬂects a diseased arterial
system. To analyze the age-related physiological changes in
several parameters, a conservative approach was used and
people with nonphysiological or pathological conditions
were excluded. Then, we excluded (a) symptomatic subjects
with or without known cardiovascular disease, (b) subjects
with personal history of cardiovascular disease, (c) subjects
with diabetes mellitus or renal failure, and (d) subjects
with cardiovascular risk factors other than age and gender.
To ensure an adequate application of the exclusion factors,
we did a medical interview in which personal and family
history and lifestyle habits were assessed by means of a
standardizedquestionnaire.Inaddition,anthropometricand
laboratory measurements (see below) were done. Subjects
referred for cardiovascular evaluation in the CUiiDARTE
Project were considered, employing a probability sampling
strategy (cluster sampling); 388 subjects were enrolled in this
study.
The subjects age range was selected in agreement with
recent international consensus that recommend both, start-
ing noninvasive arterial evaluation at ∼20 years old and
the development of programs for atherosclerosis screening
in subjects between 45–75 years old (55–75 in women)
[1, 2]. The study was approved by the Institutional Ethic
Committee (Republic University) and it was conducted
according to the Declaration of Helsinki and the Good
Clinical Practice Guidelines. CUiiDARTE Project details can
be found in: http://www.cuiidarte.fmed.edu.uy/.
Subjects were studied in a single visit. Evaluation started
after 9–12 hours overnight fast. Exercise, caﬀeine, alcohol,
and vitamin C were avoided prior (at least six hours)
to the cardiovascular examination. Subjects’ height and
weight were measured, and the body mass index (BMI,
weight to height squared ratio) calculated. Subjects with a
BMI higher than 30Kg/m2 were excluded. Family history
of premature cardiovascular disease was deﬁned as a ﬁrst
degree relative with history of cardiovascular disease at
ages younger than 55 years in men and 65 years in
women.International Journal of Hypertension 3
Table 1: Anthropometric and biochemical measurements of the seven diﬀerent age groups.
≤20 years 21–30 years 31–40 years 41–50 years 51–60 years 61–70 years 71–80 years
MV ± SD MV ± SD MV ± SD MV ± SD MV ± SD MV ± SD MV ± SD
N 74 79 43 50 59 50 33
Gender (male, %) 44 49 38 44 51 39 46
Age [years] 19.1 ± 0.2 24.8 ± 1.1 35.0 ± 2.7 45.7 ± 3.4 56.4 ± 4.0 64.3 ± 4.9 74.0 ± 3.3
Body height (cm) 167.1 ± 8.3 166.3 ± 8.2 163.1 ± 6.5 166.4 ± 10.5 159.4 ± 4.3 166.0 ± 15.1 158.0 ± 8.1
Body weight (Kg) 59.4 ± 7.6 59.9 ± 8.4 56.1 ± 6.8 63.3 ± 10.5 56.6 ± 6.5 65.7 ± 10.0 62.0 ± 8.1
Body mass index (Kg/m2) 21.3 ± 1.8 21.7 ± 4.1 21.1 ± 2.1 22.8 ± 2.2 22.3 ± 2.4 23.8 ± 0.8 24.8 ± 1.0
Total cholesterol (mg/dL) 184.8 ± 34.1 175.2 ± 24.9 190.2 ± 21.6 184.9 ± 18.3 219.4 ± 8.9 190.5 ± 21.8 183.0 ± 23.1
HDL-cholesterol (mg/dL) 63.5 ± 7.9 64.6 ± 13.8 68.0 ± 27.0 67.5 ± 6.4 73.0 ± 19.5 66.0 ± 10.2 64.0 ± 9.2
LDL-cholesterol (mg/dL) 102.0 ± 21.0 92.0 ± 19.2 111.7 ± 29.6 100.5 ± 6.4 128.7 ± 12.4 92.0 ± 12.2 90.0 ± 13.2
Triglycerides (mg/dL) 96.5 ± 47.8 85.4 ± 27.4 58.3 ± 20.5 57.5 ± 2.1 60.3 ± 20.8 64.0 ± 18.1 80.0 ± 5.1
Total cholesterol/HDL
cholesterol 2.9 ± 0.3 2.8 ± 0.6 3.0 ± 1.1 2.7 ± 0.1 3.1 ± 0.9 2.9 ± 0.2 2.8 ± 0.1
Non-HDL cholesterol 121.3 ± 27.5 110.5 ± 22.8 123.7 ± 32.3 112.0 ± 7.1 140.7 ± 16.8 124 ± 17.3 119.3 ± 19.3
Glycaemia (mg/dL) 79.3 ± 2.2 84.1 ± 5.9 69.2 ± 16.5 74.0 ± 19.1 76.0 ± 15.8 72.5 ± 6.4 82.0 ± 12.1
Family history of premature
CVD [%] 3343355
Mean (MV) ±standarddeviation(SD).HDLandLDL:highandlowdensitylipoproteincholesterol,respectively. N:numberofsubjects. CVD:cardiovascular
disease.
2.2. Laboratory Measurements. Venous blood samples were
drawn and processed immediately using commercially avail-
able kits and/or laboratory methods. Procedures were stan-
dardized before the study initiation, and during the study’s
development they were controlled for quality by a cen-
tral reference laboratory (Clinical Laboratory Department,
Clinical Hospital, School of Medicine). Total cholesterol
(TC) was determined by the spectrophotometry cholesterol
oxidase/peroxidase enzymatic method; serum triglycerides
(TG) and high density lipoprotein cholesterol (HDL-C)
were determined by glycerol enzymatic method, and the
precipitating reactive method, respectively. Low density
lipoprotein cholesterol (LDL-C) was calculated by the
Friedewald formula (LDL-C = [TC − HDL-C] − [TG/5],
valid if TG <400mg/dL) [8]. Non-HDL-C (TC − HDL-C)
and TC/HDL-C were calculated.
Lipid values were classiﬁed according to NCEP-ATP III
criteria [9]. Patients with a lipid proﬁle with one or more of
the following conditions: TG ≥200mg/dL, TC ≥240mg/dL,
HDL-C <40mg/dL, LDL-C ≥160mg/dL, and/or currently
taking antilipemic agents were excluded at the time of the
data analysis.
Subjects’ anthropometric characteristics and laboratory
data are shown in Table 1.
2.3. Noninvasive Measurements of Atherosclerotic Markers.
After blood collection, subjects were taken to the laboratory
for noninvasive vascular assessment. Vascular evaluation
consisted in measuring, using gold-standard methodologies,
complementary structural and functional vascular param-
eters. Ultrasonography (B-mode and Doppler), sphygmo-
manometry, mechanography, and applanation tonometry
t e c h n i q u e sw e r ee m p l o y e dt oe v a l u a t e / m e a s u r e
(i) common (CCA), internal (ICA), and external (ECA)
carotid arteries plaque presence;
(ii) CCA intima-media thickness (CIMT) and instanta-
neous diameter waveforms;
(iii) CCA stiﬀness (percentual pulsatility, compliance,
distensibility, and stiﬀness index);
(iv) aortic stiﬀness (carotid-femoral pulse wave velocity);
(v) peripheral and central (aortic) pressure levels and
pulse wave analysis.
2.3.1. Common (CCA), Internal (ICA), and External (ECA)
Carotid Arteries Plaque Presence: CCA Intima-Media Thick-
ness (CIMT) and Instantaneous Diameter Waveforms. Ultra-
sound evaluations in the CUiiDARTE Study are based on the
techniques and recommendations described in international
consensus [10, 11]. High-resolution B-mode carotid ultra-
sonographywasdonewithalinear-array,10MHztransducer
connected to a portable ultrasound system (MicroMaxx,
Sonosite; Bothell, Wash, USA). Measurements (still images
and video clips/cine loops) were digitally stored for oﬀ-line
analysis. Studies were done after 10–15 minutes of recum-
bent rest. Before and during ultrasound examination (at 3-
minutes intervals), brachial blood pressure measurements
were obtained using an oscillometric device (Omron HEM-
433INT Oscillometric System; Omron Healthcare Inc., Ill,
USA). The average was considered as blood pressure level.
Transverse and longitudinal views from the proximal
CCA to the peripheral segments of the ICA and ECA were
obtained, so as to assess the presence of carotid plaques
in the CCA, bulb, ICA, and ECA. Near and far walls were4 International Journal of Hypertension
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Figure 1: (a) Software employed to the CIMT and instantaneous diameter waveform measurement from B-Mode echographic videos. (b)
Software employed to the PWV measurement from the carotid (Canal 1) and femoral (Canal 1) instantaneous waveforms. (c) Software
employed to obtain the central pressure waveform (from the radial waveform recording) and to perform the peripheral and central pressure
waveform analysis. (d) Schema of the pulse wave analysis (see text).
analyzedand images were obtained fromanterior, lateral and
posterior angles. A carotid plaque was deﬁned as focal wall
thickening at least 50% greater than that of the surrounding
vessel, a thickening that protrudes into the lumen 0.5mm
or as a region with CIMT greater than 1.5mm [10]. Plaque
thicknesswasquantiﬁedatthesiteofmaximalencroachment
perpendicular to the vessel wall, and obtained by measuring
(using digital calipers and automated procedures) the dis-
tance between the media-adventitia interface and the lesion
surface facing the lumen.
After plaque screening, longitudinal views of the CCA
(obtained at the described angles), were acquired so as to
measure the CIMT and to obtain the diameter waveforms.
A video (cine-loop) of at least 10 seconds was recorded
from each angle of interrogation. The CIMT and beat-
to-beat diameter waveforms were obtained and analyzed
oﬀ-line using a step-by-step border detection algorithm
applied to each digitized image [12]( Figure 1(a)). A region
1.0cm proximal to the carotid bulb was identiﬁed, and
the far wall CIMT determined as the distance between the
lumen-intima and the media-adventitia interfaces. If there
were plaques in the area of CIMT measurement, they were
included in the measurement. The used software performs
multiple automated or semiautomated measurements along
1cm and averages them, therefore increasing the accuracy
of the measures. The instantaneous internal diameter (from
the leading edge of the near wall intima-lumen interface to
the intima-lumen interface of the far wall) waveform was
obtained (Figure 1(a)).
From the vascular echographic evaluation mechanical
parameters could be calculated (i.e., percentual distensibil-
ity) (Figure 1(a)). CCA wall-to-lumen ratio was quantiﬁed
as (CIMT/internal diastolic diameter) ∗ 100.
2.3.2. CCA Stiﬀness (Percentual Pulsatility, Compliance, Dis-
tensibility, and Stiﬀness Index). To evaluate the CCA stiﬀness
we calculated parameters that give complementary informa-
tion about the vascular behavior. Such parameters allowed
comparing our data with reported results [11]. In addition,
it is noteworthy that the stiﬀness indexes considered are
commonly used in the clinical practice, since they can be
obtained just using systolic (maximal) and diastolic (min-
imal) diameter and/or pressure values. Percentual or frac-
tional pulsatility (FP%) coeﬃcient was calculated as FP% =
((SD − DD)/DD) ∗ 100, where SD and DD are systolic and
diastolic internal diameters, respectively; CCA complianceInternational Journal of Hypertension 5
(CCA C) and distensibility (CCA D) were quantiﬁed as
CCA C = (DS – DD)/(cSBP−cDBP) and CCA D = ((DS −
DD)/DD)/(cSBP−cDBP), where cSBP and cDBP are cen-
tral systolic blood pressure and diastolic blood pressure,
respectively, obtained using Applanation Tonometry (PWA,
SphygmoCor, AtCor Medical Pty Ltd., Sydney, Australia).
Finally, the stiﬀness or Beta index (β) was calculated as: β =
Ln(cSBP/cDBP)/(SD − DD).
2.3.3. Aortic Stiﬀness (Carotid-Femoral Pulse Wave Velocity).
The carotid-femoral pulse wave velocity (PWVcf) was mea-
sured to analyze aortic regional stiﬀness. To this end, using
mechanotransducers placed simultaneously on the skin over
thecarotidandfemoralarteries(subjectsinsupineposition),
the carotid and femoral pulse waves were recorded [11,
12]( Figure 1(b)). Straight distance between the recording
sites (car-fem distance) was measured (using a tape) on
the body surface. The PWVcf was automatically calculated
as the quotient between the “car-fem” distance and the
carotid-femoral pulse transit time diﬀerence. In agreement
with international recommendations, the real PWVcf was
calculated [3]. Real PWV is a standardized PWV, obtained
if the direct “car-fem” distance and the intersecting tangent
algorithm (used to detect the carotid-femoral pulse transient
time) are used, and the value is multiplied by 0.8 (to reach
morerealisticPWVvalues)[3].ThereportedvalueofPWVcf
for a subject was always the average of at least 8 consecutive
beats. During PWV recording brachial pressure and heart
rate were quantiﬁed (Omron HEM-433INT Oscillometric
System; Omron Healthcare Inc., Ill, USA).
2.3.4. Peripheral and Central (Aortic) Pressure Levels and
Pulse Wave Analysis. Pulse wave analysis (PWA) was used
to obtain the ascending aortic pressure waveform from the
radial pulse (obtained by Applanation Tonometry) using
customized software (SphygmoCor 7.01, AtCor Medical,
Sydney, Australia) with a previously validated generalized
transfer function [13]( Figure 1(d)) .T h er a d i a lp u l s ew a v e
was obtained with the subject seated with the arm resting
on a table. The radial pulse waveform was calibrated using
the diastolic and mean pressure obtained at the brachial
artery (Omron HEM-433INT Oscillometric System; Omron
Healthcare Inc., Ill, USA) [11].
From the aortic pulse wave, central arterial pressure
was estimated, and several indexes of wave reﬂections
were quantiﬁed from the central and peripheral waveforms:
central augmentation or augmented pressure (AP), heart
ratecorrected(HR75)centralaugmentationpressure,central
augmentation index (C AGPH = (AP/PP) ∗ 100), heart
ratecorrectedcentralaugmentationindex(C AGPH HR75),
peripheral augmentation index (P AIx), and the central-
peripheral pulse pressure ampliﬁcation ratio ((peripheral
pulse pressure/central pulse pressure) ∗ 100) [14, 15]
(Figure 1(c)).
2.4. Statistical Analysis. Based on age, the 388 subjects
included (range: 18–79 years old), were divided into the
following age groups: ≤20 (n = 74), 21–30 (n = 79), 31–
40 (n = 43), 41–50 (n = 50), 51–60 (n = 59), 61–70 (n =
50), and 71–80 (n = 33) years old. Considering our aim,
the Uruguayan population, the prevalence of cardiovascular
disease and risk factors in the Uruguayan population, and
considering an α = 0.05 (C.I. = 95%), the number of
subjects included was enough to perform statistical inference
about age-related changes in arterial parameters. We used
a probability sample strategy (cluster sampling). Statistical
analyses were done using Statistical Package for the Social
Sciences 17.0 for Windows software. The data are expressed
as the mean ± standard deviation. Proportions are presented
as percentages. The correlations between the age and other
parameters were determined by a linear regression analysis.
3. Results
3.1. Peripheral and Central (Aortic) Pressure Pulse Wave
Analysis. As can be seen in Figure 2, central and peripheral
systolic blood pressure increased with age, with the steeper
increase beyond ﬁfty years.In addition, note the reduction in
thecentre-peripherysystolicpressureampliﬁcationwithage,
reaching stable values from the sixth decade (Figure 2). On
the other hand, diastolic pressure showed lesser changes with
age, but it deﬁnitely decreased beyond sixty years. Heart rate
showed a tendency to decrease with age, with major changes
over ﬁfty years (Figure 2).
Central augmentation pressure and index levels were
higher in older subjects. However, the increase diﬀered,
depending on the ages considered. For instance, the major
changes in augmentation index were observed between the
third and fourth decades (Figure 3). A similar behavior was
observed when the peripheral (radial) augmentation index
was analyzed (Figure 3).
3.2. Common (CCA), Internal (ICA), and External (ECA)
Carotid Arteries Plaque Prevalence: CCA Intima-Media
Thickness (CIMT) and Diameters. Atherosclerotic plaques
prevalence increased with age (Figure 4). About this, it is
noteworthy that while 2% of subjects between 31–40 years
showed plaques, their prevalence in subjects between the
7th and 8th decade was 67% (Figure 4). Starting in the
4th decade, the relationship decade of life—percentage of
subjects with carotid plaques—showed a linear relationship:
Plaque prevalence (%) = 15.3 ∗ (decade) – 14.6; R2 = 0.97.
Figure 4, shows the structural changes in CCA with
aging. Note that in both, left and right carotids, the diameter
and wall thickness (CIMT) increased with age. However,
the thickness changes were larger than those in diameter,
resulting in an increase in the wall-to-lumen ratio with age
(Figure 4).
3.3. CCA Stiﬀness (Percentual Pulsatility, Compliance, Dis-
tensibility, and Stiﬀness Index). Both left and right CCAs
showed a steady increase in stiﬀness with aging that was
evidenced by an increase in the stiﬀness index and a reduc-
tion in compliance, distensibility, and percentual pulsatility
(Figure 5).6 International Journal of Hypertension
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Figure 2: Peripheral (radial) and central (aortic) systolic and diastolic blood pressure (a), pulse pressure ampliﬁcation ratio (b), and heart
rate (c) age- (decade-) related proﬁles.
3.4. Aortic Stiﬀness (Carotid-Femoral Pulse Wave Velocity).
A sc a nb es e e ni nFigure 6, the studied population showed
the expected increase in the aortic regional stiﬀness (PWV
increase) with age.
4. Discussion
Despite atherosclerosis is not a normal aging change, but a
disease condition quite diﬀerent from true vascular aging,
when talking about vascular aging in humans, the analysis is
frequently referred to atherosclerosis and its prevalence with
age [14, 15]. Furthermore, the study of humans aging has
haddiﬃcultiesinseparatingagingprocessfromconcomitant
disease and/or in deﬁning normality and abnormality in
the aging process. About this, aging associates structural
and functional changes evidenced in variations in vascular
parametersthataremodiﬁedduringatherosclerosisandhave
been proposed as early markers of disease. That stated above
could contribute to explain the controversial and/or limited
data about age-related cardiovascular changes in diﬀerent
populations. The lack of adequate tools to diﬀerentiate the
expected (normal) vascular changes due to aging and those
related with vascular disease is not a minor issue. About
this, it should be kept in mind that for an individual an
early diagnosis of vascular disease would be as important
as the diagnosis of healthy vascular aging. In this context,
this work has the strength of being the ﬁrst that uses in Latin
America an integrative approach, applied to characterize in a
Uruguayan population, the vascular structural and functional
changes expected with aging. In turn, the obtained data would
be used to deﬁne vascular changes not explained by the aging
process (abnormal or disease-related vascular changes).
Several studies have explored the relationship between
cardiovascular disease and CIMT in diﬀerent ethnic pop-
ulations. The studies’ results support the use of CIMT
measurement as a surrogate marker of vascular disease,International Journal of Hypertension 7
< 20 21–30 31–40 41–50 51–60 61–70 71–80
Age (years)
−10
0
10
20
30
40
50
Central augmentation pressure (mmHg)
Lineal (central augmentation pressure (mmHg))
Central augmentation pressure-HR75
Lineal (central augmentation pressure-HR75)
C
e
n
t
r
e
a
l
(
a
o
r
t
i
c
)
a
u
g
m
e
n
t
a
t
i
o
n
p
r
e
s
s
u
r
e
(
m
m
H
g
)
y = 5.1271x −7.8051 R2 = 0.8818
y = 3.9789x −5.5043 R2 = 0.9188
(a)
< 20 21–30 31–40 41–50 51–60 61–70 71–80
Age (years)
−10
−20
0
10
20
30
40
50
y = 6.3417x −0.9583 R2 = 0.9371
y = 5.2619x +0.7953 R2 = 0.8515
C AGPH
Lineal (C AGPH)
C AGPH HR75
Lineal (C AGPH HR75)
C
e
n
t
r
e
a
l
(
a
o
r
t
i
c
)
a
u
g
m
e
n
t
a
t
i
o
n
i
n
d
e
x
(
%
)
(b)
y = 9.1418x +43.595
R2 = 0.9292
P
e
r
i
p
h
e
r
a
l
(
r
a
d
i
a
l
)
a
u
g
m
e
n
t
a
t
i
o
n
i
n
d
e
x
(
%
)
0
20
40
60
80
100
120
< 20 21–30 31–40 41–50 51–60 61–70 71–80
Age (years)
(c)
Figure 3: Peripheral (a) and central (b and c) wave reﬂections indexes age- (decade-) related proﬁles.
at the time they establish that changes in CIMT could
not be considered a disease synonymous [10, 14, 15]. In
addition, the studies’ results agree in that CIMT increases
with advancing age. However, it is noteworthy that among
the populations in which CIMT was studied, there were
diﬀerences in both, the CIMT normal levels and its changes
inassociationwithdiﬀerentfactors[7,14,15].Thisissuewas
recently assessed in the Cardiovascular Risk Factor Multiple
Evaluation in Latin America study (CARMELA) [7], which
results underlined the diﬀerences in age eﬀects across cities.
In this work, and in line with the described changes
in CIMT associated with aging, we found an age-related
steady increase in the CIMT, in both left and right CCA,
with a higher CIMT in the left CCA beyond 40s, in
agreement with other authors’ ﬁndings (Figure 4)[ 16, 17].
As a whole, our population showed an average CIMT
increase of 0.008mm/year beyond the third decade of life.
Then, analyzing our data taking into account those of the
CARMELA study, it could be said that the CIMT in the
studied Uruguayan population shows similar but not equal
levels and age-related changes when compared to other Latin
American populations [7]. This is also true when our results
are analyzed comparing them with those obtained in other
populations. About this, the age-related changes in CIMT
found in our population showed a behavior located in the
middle between the group in which the variation is large8 International Journal of Hypertension
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Figure 4: Carotid atherosclerotic plaque prevalence (a) and common carotid artery (CCA) intima-media thickness (b), diameters (c), and
wall-to-lumen ratio (d) age- (decade-) related proﬁles.
(>0.01mm/year), consisting of USA [18, 19], central Europe
[20–22] and Nordic countries [23], and that with minor age
eﬀects, which comprises Spain [24], France [23, 25], and
Japan [26, 27]. Taking into account that discussed above,
and as was previously suggested, since CIMT levels and
changes would diﬀer among regions and ethnic groups,
the CIMT distribution in a particular population must be
deﬁned prior to its use in cardiovascular diagnosis and/orInternational Journal of Hypertension 9
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Figure 5: Common carotid artery (CCA) local stiﬀness parameters. CCA percentual or fractional pulsatility (a), compliance (b),
distensibility (c), and Beta or stiﬀness index (d) age- (decade-) related proﬁles.
risk stratiﬁcation [7]. As will be discussed, the necessity
of a population-based determination of normal/reference
values is also applicable for other vascular parameters, if an
adequate vascular evaluation is to be done.
The age-related vascular structural changes found in our
population also included an increase in both systolic and
diastolic vascular diameters (Figure 4). It should be noted
that although we observed a steady diameter dilatation with10 International Journal of Hypertension
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Figure 6: Measured and “real” carotid-femoral pulse wave velocity
(PWVcf) age- (decade-) related proﬁles.
age, it was steeper beyond the sixth decade. Changes in
central arteries diameter with aging have been previously
described and associated with changes in the media layer
of the arterial wall (media disorganization and elastic ﬁbers
degeneration) [14, 15, 28]. However, the major increase in
wall thickness (CIMT) compared with that of the diameter
resulted in an age-related increase in the wall to lumen ratio
(Figure 4). Analyzing the meaning of the CCA “structural
remodeling” found in our population, in the context of the
hemodynamic (i.e., pressure changes) variations it showed
in association with aging, was beyond this work aims and
should be assessed in future works. Anyway, it should
be mentioned that we found a reduction in the CCA
circumferential stress with age (data not published).
Blood pressure changes with age have been evaluated in
several studies and it has been described that systolic blood
pressure increases with advancing age [14, 15]. Anyway, age-
related pressure variations would not be uniform and would
showdiﬀerencesdependingonthepopulationcharacteristics
[14, 15]. On the other hand, little changes have been
described in diastolic pressure at least until age 60, beyond
which a deﬁned reduction in diastolic pressure has been
described [14, 15, 29]. Our population showed the expected
age-related changes in systolic and diastolic pressure, for
both central (aortic) and peripheral (radial) pressure levels
(Figure 2). Furthermore, it is noteworthy that the systolic
(central and peripheral) pressure variations showed a steeper
increase beyond the sixth decade. In addition, beyond that
age, the centre-periphery systolic ampliﬁcation remained
constant, which is in agreement with previous works [14, 15,
30].
Pressure changes have been associated with changes
in vascular stiﬀness. About this, manifestations of arterial
stiﬀness include its eﬀects on the arterial pressure levels and
wave [31]. In addition, it should be noted that vascular
(mainly at the aortic and central arteries levels) stiﬀening has
been described as a true aging change; a fact not accepted by
some authors and that would vary depending on the subjects
characteristics [14, 15]. In this context, we found an increase
in waves’ reﬂections (evidenced by central and peripheral
wavereﬂectionparameters)withage(Figure 3)andthatboth
the CCA and the aorta progressively stiﬀen with aging, as
was evidenced by the CCA distensibility and compliance
reduction and by the increase in the CCA stiﬀness index
(Figure 5)a n dP W V( Figure 6). These ﬁndings agree with
published data [14, 15, 32, 33].
In agreement with our ﬁndings, recently Boutouyrie and
Vermeersch [3] performed an important study in which
PWV recordings from 16.867 subjects from 13 diﬀerent
centers across eight European countries were collected.
Among the included subjects, those (n = 11.092) free from
overt cardiovascular disease, nondiabetic, and untreated by
either antihypertensive or lipid-lowering drugs constituted
the reference value population. Subjects were categorized
by age decade and further subdivided according to BP
categories. From the authors’ data, regression lines for mean
“real” PWV, considering the subjects blood pressure levels
were: PWV (m/s) = 0.97 ∗ decade + 4.26 (optimal pressure),
PWV (m/s) = 1.20 ∗ decade + 4.02 (normal pressure), PWV
(m/s) =1.18 ∗ decade + 4.46 (high normal pressure), and
PWV (m/s) = 1.37 ∗ decade + 5.79 (grade 1 HTA). In
our population of nonhypertensive patients, the relationship
was PWV (m/s) = 1.22 ∗ decade + 4.96 (Figure 6). Then,
our population showed a rate of PWV increase (0.12m/s
per year) that would be comparable to that found in by
Boutouyrie and Vermeersch for nonhypertensive subjects.
On the other hand, it is to note that in average, the subjects
included in our study showed higher PWV levels than those
includedinBoutouyrieandVermeerschwork[3].Themean-
ingofthediﬀerencesinPWV,andthemechanismsthatcould
explain them should be analyzed in future works. Anyway,
those diﬀerences, add support to that mentioned above
related with the importance of obtaining population-based
normal/reference values to perform a correct interpretation
of a subject vascular evaluation.
Finally, it would be worth mentioning that we found
an aging increase in the prevalence of atherosclerotic
plaques (Figure 4). Such age-related increase in the number
of atheroma plaques is in agreement with the described
augmented prevalence of atherosclerosis with age [14, 15]. In
particular, it is noteworthy that for both, males and females,
Joakimsen et al. [34] described and increase in the number
of plaques diagnosed from the fourth until the ninth decade.
Furthermore, in agreement with our ﬁndings, the authors
described that the predilection site of atherosclerosis was the
bifurcation segment of the carotid artery, for both sexes at
anyage[34].Ifthereareage-relateddiﬀerencesintheplaques
characteristics (biomechanical and/or structural properties)
would be an interesting issue to be assessed in future works.International Journal of Hypertension 11
Finally, it is noteworthy that future works are necessary
to analyze how cardiovascular risk factors impact on the
expected changes associated with aging and to determine
normal and reference values for the diﬀerent vascular
parameters. In turn, that should be done taking into account
possible gender diﬀerences.
5. Conclusions
Age-related structural and functional vascular parameters
proﬁles were obtained in the context of the CUiiDARTE
Project, using gold standard methodologies and techniques,
for a Uruguayan asymptomatic population, and analyzed
taking into account available data from other populations.
The work has the strength of being the ﬁrst in Latin
America that applies an integrative approach to characterize
age-related structural (i.e., CIMT, Diameter, wall-to-lumen
ratio) and functional (i.e., CCA stiﬀness, aortic stiﬀness,
peripheral, and central pressure waveform indexes) param-
eters using gold standard techniques.
Theobtaineddatacouldbeusedinthevasculardiagnosis
to deﬁne/diﬀerentiate normal changes and abnormal or
disease-related vascular variations.
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